{"version":"1.0","provider_name":"Canadian Digestive Health Foundation","provider_url":"https:\/\/cdhf.ca\/en\/","author_name":"Kelsey Cheyne","author_url":"https:\/\/cdhf.ca\/en\/author\/kelsey-cheyne\/","title":"Understanding S1P Receptor Modulator Therapy for Ulcerative Colitis\u00a0 - Canadian Digestive Health Foundation","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"nunjj6JejX\"><a href=\"https:\/\/cdhf.ca\/en\/understanding-s1p-receptor-modulator-therapy-for-ulcerative-colitis\/\">Understanding S1P Receptor Modulator Therapy for Ulcerative Colitis\u00a0<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cdhf.ca\/en\/understanding-s1p-receptor-modulator-therapy-for-ulcerative-colitis\/embed\/#?secret=nunjj6JejX\" width=\"600\" height=\"338\" title=\"&#8220;Understanding S1P Receptor Modulator Therapy for Ulcerative Colitis\u00a0&#8221; &#8212; Canadian Digestive Health Foundation\" data-secret=\"nunjj6JejX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/cdhf.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/09\/Banners-for-Website-Size-88-1024x461.png","thumbnail_width":1024,"thumbnail_height":461,"description":"Inflammatory Bowel Disease is a challenging and often debilitating condition that affects approximately 322,600 people in Canada. Ulcerative colitis (UC) and Crohn\u2019s disease are forms of inflammatory bowel disease (IBD), that is characterized by chronic inflammation of the gastrointestinal tract. Specifically, UC affects the colon and rectum, leading to symptoms such as abdominal pain, diarrhea, [&hellip;]"}